These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4022928)

  • 21. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
    Nolte D; Dusik B
    Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined administration of controlled release theophylline and ranitidine: a 53-day controlled survey in patients with chronic obstructive lung disease (COLD) and peptic disease.
    Dal Negro R; Turco P; Pomari C; Trevisan F; De Conti F; Cordaro CI
    Br J Clin Pract; 1987 Nov; 41(11):1004-8. PubMed ID: 3504314
    [No Abstract]   [Full Text] [Related]  

  • 23. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic non-compliance in patients with chronic airway obstruction].
    Barrueco M; Otero MJ; Fernández de Gatta MR; Martín J; de Portugal J; Domínguez-Gil A
    Rev Clin Esp; 1987 Apr; 180(6):293-5. PubMed ID: 3602534
    [No Abstract]   [Full Text] [Related]  

  • 26. [Microcrystallinic theophylline, plasma concentration and adverse effects in patients with obstructive lung disease].
    Talseth T; Kongerud J; Boye NP; Bredesen JE
    Tidsskr Nor Laegeforen; 1981 Oct; 101(29):1648-50. PubMed ID: 7339948
    [No Abstract]   [Full Text] [Related]  

  • 27. Categorisation of ventilatory pattern of response to bronchodilator therapy in airflow limitation.
    Meenakshi S
    J Assoc Physicians India; 1995 Mar; 43(3):179-81. PubMed ID: 11256903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of nifedipine on patients with chronic obstructive lung disease.
    Ikeda H; Takahashi K; Sasaki H; Ito E; Yasui S
    Arzneimittelforschung; 1985; 35(2):518-21. PubMed ID: 4039574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Optimizing of therapy with theophylline preparations in obstructive respiratory diseases. 4. Effect of theophylline on mucociliary clearance and maximal inspiratory mouth occlusion pressure].
    Schmidt G; Ranke C; Creutzig H; Oellerich M; Sybrecht GW
    Prax Klin Pneumol; 1983 Apr; 37(4):154-60. PubMed ID: 6866926
    [No Abstract]   [Full Text] [Related]  

  • 30. [Theophylline--once or twice daily?].
    Schoch C; Menz G; Virchow C
    Fortschr Med; 1987 May; 105(16):319-22. PubMed ID: 3301601
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline.
    Tsukagoshi H; Shimizu Y; Iwamae S; Hisada T; Ishizuka T; Iizuka K; Dobashi K; Mori M
    Respir Med; 2000 Jun; 94(6):584-8. PubMed ID: 10921764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
    van der Vet AP; Kreukniet J; Drost RH; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

  • 34. Nedocromil sodium versus theophylline in the treatment of reversible obstructive airway disease.
    Crimi E; Orefice U; De Benedetto F; Grassi V; Brusasco V
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):501-8. PubMed ID: 7788518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
    Eichhorn J; Perré R
    Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
    [No Abstract]   [Full Text] [Related]  

  • 36. [Is there a renaissance of oral theophylline therapy in chronic obstructive airway syndrome?].
    Fenner HG
    ZFA (Stuttgart); 1981 Jul; 57(21):1480-4. PubMed ID: 7281936
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.
    Stănescu DC; Clément J; Van de Woestijne KP
    Thorax; 1973 Nov; 28(6):716-20. PubMed ID: 4787983
    [No Abstract]   [Full Text] [Related]  

  • 38. [Theophylline in the therapy of non reversible airway obstruction].
    Drigo R; Bevilacqua M; Franco R
    G Clin Med; 1987 Jan; 68(1):39-45. PubMed ID: 3301490
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of chronic airway obstruction: theophylline--is it still necessary?
    Ukena D; Sybrecht GW
    Lung; 1990; 168 Suppl():627-33. PubMed ID: 2117173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Theophylline treatment of irreversible, chronic obstructive pulmonary disease].
    Iversen ET; Eiken PA; Nielsen LM; Laursen LC; Maltbaek N; Tønnesen FV; Rasmussen FV
    Ugeskr Laeger; 1994 Sep; 156(39):5696-9. PubMed ID: 7985256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.